Dec. 13 at 7:41 PM
$AKBA To all the pumpers and fudsters, Stop! I’ve seen all the nonsense on this board throughout the year. The company will be around for years; they’ve already raised money from us, so they’ll be fine. If you're looking for a quick pump, it might happen and take us to
$2.50 with better revenue from Vasfeo.
And to the pumpers dreaming of
$30, go outside and touch some grass and come back when you're more grounded.
As for the extreme bears, this company is here for the long haul, even if the price drops. It's not going bankrupt anytime soon, not for decades to come.
And as I’ve always said, the best return for shareholders would be a buyout. The longer this company stays on the market, the more risk we take. The valuation could go up or down depending on how the pipeline progresses. For example, If Phase 2 results are bad, the valuation drops; if they’re good, it rises. That’s too much risk and too much waiting for a small biotech that’s been around for nearly 15 years as public company
